$INDV

$34.72 +$0.16 (0.46%) Close

$INDV Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 118.0M shares outstanding

Who owns INDV?

By type of holder

Institutions 100.0% Insiders 0.0% Everyone else 0.0%

Concentration Top 10 holders own 49.7%

BlackRock, Inc. 15.9% · Vanguard Portfolio Management LLC 6.4%

Institutional ownership

100.0%

0 pts vs last qtr

Institutional holders

335

+46 vs last qtr

Net shares bought

−6.5M

by institutions in Q2 2026

New / sold out

87 / 41

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Franklin Resources Inc +3.2M
Assenagon Asset Management S.A. NEW +1.5M

Biggest sellers in Q2 2026

Millennium Management LLC −2.5M
Goldman Sachs Group Inc −1.7M

Who is planning to sell?

Notices of proposed sale, last 12 months

$6.56M

4 notices from 3 people

Shares covered

194.9K

0.17% of the company

Arranged in advance

43%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Cetani Cynthia C Officer $3.73M
Heidbreder Christian Officer 10b5-1 $1.47M

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2022–FY2025

−7.9%

−2.71% a year

Each share's claim on the business

+8.6%

grew without buying or selling a share

Spent on buybacks vs paid in stock

$307M vs $87M

over 4 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years27% 1–3 years44% Under 1 year29%

Quarterly turnover

15.1%

of institutional shares changed hands

Top 10 managers, median time held

3 years

Super Investors

Investment managers reporting INDV on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
B BlackRock, Inc.	18.7M	15.85%	+167.2K (+0.9%)	2024	0.0%
Shares held by quarter Peak holding18.7M (Q2'26) Change over 8 quarters+18.7M Share of the company15.850% BlackRock, Inc.'s full portfolio →
VP Vanguard Portfolio Management LLC	7.6M	6.42%	−319.5K (−4.0%)	2023	0.0%
Shares held by quarter Peak holding7.9M (Q1'26) Change over 8 quarters+7.6M Share of the company6.420% Vanguard Portfolio Management LLC's full portfolio →

BlackRock, Inc.

18.7M

% of company

15.85%

Change vs last qtr

+167.2K (+0.9%)

Held since

2024

Vanguard Portfolio Management LLC

7.6M

% of company

6.42%

Change vs last qtr

−319.5K (−4.0%)

Held since

2023

28 more super investors behind a free account

See every manager holding Indivior Pharmaceuticals Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting INDV on Form N-PORT; together they hold 43.9% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
IC iShares Core S&P Small-Cap ETF iShares Trust	$301M	7.3M	6.22%	0.27%	June 30, 2026
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$159M	3.9M	3.28%	0.01%	June 30, 2026

iShares Core S&P Small-Cap ETF

iShares Trust

Position value

$301M

% of company

6.22%

% of the fund

0.27%

As of

June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$159M

% of company

3.28%

% of the fund

0.01%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Indivior Pharmaceuticals Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
OC Oaktree Capital Holdings, LLC 5%+ holder 13D · 0.8%	909.1K	0.77%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company0.770% Disclosed stake13D · 0.8% View the 13D/G filing →
CJ Ciaffoni Joseph Insider	790.3K	0.67%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.670% Ciaffoni Joseph's insider activity →

Oaktree Capital Holdings, LLC

5%+ holder13D · 0.8%

909.1K

% of company

0.77%

Change vs last qtr

—

Held since

—

Ciaffoni Joseph

Insider

790.3K

% of company

0.67%

Change vs last qtr

—

Held since

—

12 more holders behind a free account

See every insider and 5%+ holder of Indivior Pharmaceuticals Inc.

Comments